Decreased CSF Aβ40 and Aβ42 levels in candidates for anti-amyloid therapy with advanced MRI-visible perivascular spaces in the centrum semiovale
Puntos clave
Decreased levels of CSF Aβ40 and Aβ42 indicate a significant finding in candidates for therapy.
CSF Aβ40 and Aβ42 levels were notably lower among those with advanced MRI-visible perivascular spaces.
Observational analysis assessed CSF levels and MRI findings in relation to anti-amyloid therapy.
Implication highlights the potential for these biomarkers in identifying suitable candidates for intervention.
Me gusta
Guardar
Compartir
Me gusta
Guardar
Compartir
Decreased CSF Aβ40 and Aβ42 levels in candidates for anti-amyloid therapy with advanced MRI-visible perivascular spaces in the centrum semiovale | Synapse